IBM shares weekly forecast: Resistance at the 50-day moving average caps recovery attempts

IBM shares weekly forecast: Resistance at the 50-day moving average caps recovery attempts
IBM falls 1.23% over the week

Shares of International Business Machines Corporation (IBM) are trading near $223 after falling more than 1% last week, as support comes into focus following an extended sell-off. Corporate updates and product moves shape expectations for the next week, with attention on whether prices will stabilize or continue to test lower levels.

IBM price prediction
24H 2.99%
$253.44
48H 2.74%
$252.82
7D 0.72%
$247.86
1M 14.66%
$282.16
3M 9.74%
$270.06
6M -8.46%
$225.26
12M -15.04%
$209.08
Current price: $246.08 -6.4900 2.57%
Real-time Data 09:53
Daily range 252.43 Arrow from to Icon 259.84
Weekly range 247.74 Arrow from to Icon 259.84
Loading...

Highlights

  • Shares of IBM have declined to $222.79 over the past week and remain below key short-term moving averages.
  • Technical indicators show oversold conditions and ongoing downside pressure, with momentum remaining weak and no reversal signals present.
  • The range for the next five trading days is projected between $214.58 and $230.99, with a higher probability of further losses.

Product expansion and recurring revenue guide sentiment as dividend debate lingers

IBM announced on September 24, 2026, the expansion of its digital asset infrastructure, enabling clients to interact with permissioned blockchain networks such as Swift’s shared ledger, according to PR Newswire. Additionally, the company continues to highlight growth in recurring software revenue, as reported by Pluang. Dividend sustainability remains a background topic, while a recent roundup from finanzen.ch noted that a one-year investment in IBM shares would have resulted in a loss, excluding dividends and stock splits.

IBM asset chart
IBM price dynamics. Source: TradingView.

Oversold signals intensify as weak weekly momentum drives downside risk

The daily setup shows a flat trend with a sharp move lower without a sustained trend, as volatility over the past week reached 8.37%. RSI is approaching oversold at 37.81, while both CCI and Stochastic RSI are deeply oversold, signaling lingering downside pressure. Nearest support is seen at $219.23, with resistance at the 50-day moving average of $230.83 and the Ichimoku Kijun at $235.49 acting as an additional barrier above. This technical alignment points to continued downside risk, with weak momentum and few signs of reversal so far.

Consolidation base expected as downside bias dominates next week’s scenarios

For the next five trading days, the expected range is $214.58 to $230.99. There is a 22% probability of an increase and a 78% probability of a decrease. The base case is for IBM shares to consolidate between $219.23 support and resistance at $230.83. A move above $230.83 would open the door to a test of higher resistance, while a drop below $219.23 could see the stock extend losses toward the lower bound of the expected range.

Jainam Mehta, market strategist, sees IBM shares trading near $223 after a week marked by continued volatility and technical weakness. Mehta notes IBM’s recent expansion into digital asset infrastructure and steady growth in recurring software revenue point to long-term potential, but these fundamentals have yet to spark a reversal in price action. With RSI approaching oversold and support at $219.23 in focus, risks remain skewed to further downside unless momentum shifts. "I am watching for stabilization above $219.23, but with a 78% probability of a downside move and few signs of reversal, base case is for consolidation and capital preservation this week."

Earlier, analysts noted that IBM remained under bearish momentum, constrained by weak technical conditions despite efforts to expand its digital banking infrastructure. With current technical signals still pointing to downside risk, traders should monitor $219.23 as a key support level for potential further declines in the coming sessions.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.